An integrated cell atlas of the lung in health and disease

Lisa Sikkema(Helmholtz Zentrum München), Ciro Ramírez-Suástegui(La Jolla Institute for Immunology), Daniel Strobl(Helmholtz Zentrum München), Tessa E. Gillett(University Medical Center Groningen), Luke Zappia(Helmholtz Zentrum München), Elo Madissoon(Wellcome Sanger Institute), Nikolay S. Markov(Northwestern University), Laure‐Emmanuelle Zaragosi(Centre National de la Recherche Scientifique), Yuge Ji(Helmholtz Zentrum München), Meshal Ansari(Helmholtz Zentrum München), Marie‐Jeanne Arguel(Centre National de la Recherche Scientifique), Leonie Apperloo(University Medical Center Groningen), Martin Banchero(University Medical Center Groningen), Christophe Bécavin(Centre National de la Recherche Scientifique), Marijn Berg(University Medical Center Groningen), Evgeny Chichelnitskiy(Medizinische Hochschule Hannover), Mei-I Chung(Translational Genomics Research Institute), Antoine Collin(Centre National de la Recherche Scientifique), Aurore Gay(University Medical Center Groningen), Janine Gote-Schniering(German Center for Lung Research), Baharak Hooshiar Kashani(German Center for Lung Research), Kemal İnecik(Helmholtz Zentrum München), Manu Jain(Northwestern University), Theodore S. Kapellos(University of Bonn), Tessa Kole(University Medical Center Groningen), Sylvie Leroy(Université Côte d'Azur), Christoph H. Mayr(German Center for Lung Research), Amanda J. Oliver(Wellcome Sanger Institute), Michael von Papen, Lance Peter(Translational Genomics Research Institute), Chase J. Taylor(Vanderbilt University Medical Center), Thomas Walzthoeni(Helmholtz Zentrum München), Chuan Xu(Wellcome Sanger Institute), Linh T. Bui(Translational Genomics Research Institute), Carlo De Donno(Helmholtz Zentrum München), Leander Dony(Helmholtz Zentrum München), Alen Faiz(University of Technology Sydney), Minzhe Guo(Cincinnati Children's Hospital Medical Center), Austin J. Gutierrez(Translational Genomics Research Institute), Lukas Heumos(Helmholtz Zentrum München), Ni Huang(Wellcome Sanger Institute), Ignacio L. Ibarra(Helmholtz Zentrum München), Nathan D. Jackson(National Jewish Health), Preetish Kadur Lakshminarasimha Murthy(Duke University), Mohammad Lotfollahi(Wellcome Sanger Institute), Tracy Tabib(University of Pittsburgh), Carlos Talavera‐López(Helmholtz Zentrum München), Kyle J. Travaglini(Allen Institute for Brain Science), Anna Wilbrey-Clark(Wellcome Sanger Institute), Kaylee B. Worlock(University College London), Masahiro Yoshida(University College London), Yuexin Chen(German Center for Lung Research), James S. Hagood(University of North Carolina at Chapel Hill), Ahmed Agami(German Center for Lung Research), Péter Horváth(University of Helsinki), Joakim Lundeberg(KTH Royal Institute of Technology), Charles‐Hugo Marquette(Université Côte d'Azur), Gloria Pryhuber(University of Rochester Medical Center), Chistos Samakovlis(Stockholm University), Xin Sun(University of California San Diego), Lorraine B. Ware(Vanderbilt University Medical Center), Kun Zhang(University of California San Diego), Maarten van den Berge(University Medical Center Groningen), Yohan Bossé(Institut universitaire de cardiologie et de pneumologie de Québec), Tushar Desai(Stanford University), Oliver Eickelberg(University of Pittsburgh), Naftali Kaminski(Yale University), Mark A. Krasnow(Howard Hughes Medical Institute), Robert Lafyatis(University of Pittsburgh), Marko Nikolić(University College London), Joseph E. Powell(Garvan Institute of Medical Research), Jayaraj Rajagopal(Harvard University), Mauricio Rojas(The Ohio State University), Orit Rozenblatt–Rosen(Broad Institute), Max A. Seibold(National Jewish Health), Dean Sheppard(University of California, San Francisco), Douglas P. Shepherd(Arizona State University), Don D. Sin(University of British Columbia), Wim Timens(University Medical Center Groningen), Alexander M. Tsankov(Icahn School of Medicine at Mount Sinai), Jeffrey A. Whitsett(Cincinnati Children's Hospital Medical Center), Yan Xu(Cincinnati Children's Hospital Medical Center), Nicholas E. Banovich(Translational Genomics Research Institute), Pascal Barbry(Centre National de la Recherche Scientifique), Thu Elizabeth Duong(University of California San Diego), Christine S. Falk(Medizinische Hochschule Hannover), Kerstin B. Meyer(Wellcome Sanger Institute), Jonathan A. Kropski(Vanderbilt University), Dana Pe’er(Memorial Sloan Kettering Cancer Center), Herbert B. Schiller(German Center for Lung Research), Purushothama Rao Tata(Duke University), Joachim L. Schultze(University of Bonn), Sara A. Teichmann(University of Cambridge), Alexander V. Misharin(Northwestern University), Martijn C. Nawijn(University Medical Center Groningen), Malte D. Luecken(Helmholtz Zentrum München), Fabian J. Theis(Helmholtz Zentrum München)
Nature Medicine
June 1, 2023
Cited by 739Open Access
Full Text

Abstract

Abstract Single-cell technologies have transformed our understanding of human tissues. Yet, studies typically capture only a limited number of donors and disagree on cell type definitions. Integrating many single-cell datasets can address these limitations of individual studies and capture the variability present in the population. Here we present the integrated Human Lung Cell Atlas (HLCA), combining 49 datasets of the human respiratory system into a single atlas spanning over 2.4 million cells from 486 individuals. The HLCA presents a consensus cell type re-annotation with matching marker genes, including annotations of rare and previously undescribed cell types. Leveraging the number and diversity of individuals in the HLCA, we identify gene modules that are associated with demographic covariates such as age, sex and body mass index, as well as gene modules changing expression along the proximal-to-distal axis of the bronchial tree. Mapping new data to the HLCA enables rapid data annotation and interpretation. Using the HLCA as a reference for the study of disease, we identify shared cell states across multiple lung diseases, including SPP1 + profibrotic monocyte-derived macrophages in COVID-19, pulmonary fibrosis and lung carcinoma. Overall, the HLCA serves as an example for the development and use of large-scale, cross-dataset organ atlases within the Human Cell Atlas.


Related Papers